Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test
- 1 March 2001
- journal article
- research article
- Published by SAGE Publications in Perfusion
- Vol. 16 (2) , 147-153
- https://doi.org/10.1177/026765910101600209
Abstract
Patients undergoing cardiopulmonary bypass (CPB) require anticoagulation with heparin to avoid thrombosis within the bypass circuit. The common method used to monitor the degree of anticoagulation is the activated clotting time (ACT). We evaluated a novel point of care device, the TAS (Pharmanetics, Raleigh, NC, USA) heparin management test (HMT), for its suitability in monitoring anticoagulation during CPB. In vitro analysis showed a dose-response ( r2=0.988) of the HMT from 0.078-10.0 U/ml heparin, covering the range of heparin used during cardiac surgery (2-5 U/ml). Fifty randomly selected patients undergoing CPB were studied. Preheparin clotting times for these patients were 143±32 s for the HMT and 146±18 s for the ACT; 435±60 s HMT and 438±39 s ACT during CPB; 145±50 s HMT and 128±14 s ACT post-protamine ( r2=0.797). ε-Aminocaproic acid treatment for inhibition of fibrinolysis did not affect the HMT. We conclude that the HMT correlates well with the ACT and may be useful for monitoring heparin during CPB. Advantages of the HMT are small sample volume and good sensitivity to heparin.Keywords
This publication has 17 references indexed in Scilit:
- Anticoagulation Monitoring during Cardiac SurgeryAnesthesiology, 1999
- Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1996
- More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACTThrombosis and Haemostasis, 1996
- Effects of aprotinin on anticoagulant monitoring: Implications in cardiovascular surgeryThe Annals of Thoracic Surgery, 1993
- Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysisClinical Chemistry, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Synthetic Peptide Substrate Assays in Coagulation and Fibrinolysis and Their Application on AutomatesSeminars in Thrombosis and Hemostasis, 1983
- Newer Avenues in the Monitoring of Antithrombotic Therapy: The Role of AutomationSeminars in Thrombosis and Hemostasis, 1983
- Activated Clotting Times and Cardiopulmonary Bypass I: The Effect of Hemodilution and Hypothermia upon Activated Clotting TimeThe Journal of ExtraCorporeal Technology, 1980
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975